An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer

Introduction: The aim of the study was to determine the adaption of neoadjuvant chemotherapy (NAC) in patients with muscle-invasive bladder cancer (MIBC) in Germany, Austria, and Switzerland and especially underlying reasons for potential low adherence to guidelines. Methods: We conducted a non-vali...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Reike, Moritz (VerfasserIn) , Reicherz, Alina (VerfasserIn) , Tully, Karl H. (VerfasserIn) , Bahlburg, Henning (VerfasserIn) , Maas, Moritz (VerfasserIn) , Bach, Peter (VerfasserIn) , Klümper, Niklas (VerfasserIn) , Eckstein, Markus (VerfasserIn) , Hartmann, Arndt (VerfasserIn) , Breyer, Johannes (VerfasserIn) , Erben, Philipp (VerfasserIn) , Bolenz, Christian (VerfasserIn) , Noldus, Joachim (VerfasserIn) , Berg, Sebastian (VerfasserIn) , Roghmann, Florian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 2024
In: Urologia internationalis
Year: 2024, Jahrgang: 108, Heft: 3, Pages: 183-189
ISSN:1423-0399
DOI:10.1159/000536321
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000536321
Verlag, lizenzpflichtig, Volltext: https://karger.com/uin/article-abstract/108/3/183/894478/An-Empirical-Survey-on-the-Adaption-of-Neoadjuvant?redirectedFrom=fulltext
Volltext
Verfasserangaben:Moritz J. Reike, Alina Reicherz, Karl H. Tully, Henning Bahlburg, Moritz Maas, Peter Bach, Niklas Klümper, Markus Eckstein, Arndt Hartmann, Johannes Breyer, Philipp Erben, Christian Bolenz, Joachim Noldus, Sebastian Berg, Florian Roghmann

MARC

LEADER 00000caa a22000002c 4500
001 191534414X
003 DE-627
005 20250716223629.0
007 cr uuu---uuuuu
008 250122s2024 xx |||||o 00| ||eng c
024 7 |a 10.1159/000536321  |2 doi 
035 |a (DE-627)191534414X 
035 |a (DE-599)KXP191534414X 
035 |a (OCoLC)1528016544 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Reike, Moritz  |d 1990-  |e VerfasserIn  |0 (DE-588)116011286X  |0 (DE-627)1023273055  |0 (DE-576)505530457  |4 aut 
245 1 3 |a An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer  |c Moritz J. Reike, Alina Reicherz, Karl H. Tully, Henning Bahlburg, Moritz Maas, Peter Bach, Niklas Klümper, Markus Eckstein, Arndt Hartmann, Johannes Breyer, Philipp Erben, Christian Bolenz, Joachim Noldus, Sebastian Berg, Florian Roghmann 
264 1 |c June 2024 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlich: 19. Januar 2024 
500 |a Gesehen am 22.01.2025 
520 |a Introduction: The aim of the study was to determine the adaption of neoadjuvant chemotherapy (NAC) in patients with muscle-invasive bladder cancer (MIBC) in Germany, Austria, and Switzerland and especially underlying reasons for potential low adherence to guidelines. Methods: We conducted a non-validated survey among 336 urologic departments in Germany, Austria, and Switzerland. RedCap questionnaires were electronically distributed and included 23 items concerning the general NAC administration standards and guideline compliance in patient counseling regarding the actual treatment. Results: The return rate of the questionnaire was 19.1% (63/336). Although 45 departments (71.4%) claim to perform NAC as the standard of care, only 49% of eligible patients actually receive NAC. An advanced disease stage (≥cT3) and a high tumor volume were mentioned to support the application of NAC, whereas 35% of responders worry about deterioration of patients’ preoperative status due to NAC. Furthermore, 26.7% of respondents are concerned about the low extent of survival benefit. Conclusion: Application of NAC in eligible MIBC patients in Germany, Austria, and Switzerland remains low. Although the majority of urologic departments discuss NAC and acknowledge the need for intensified treatment in advanced disease stages, not all eligible patients will actually receive NAC before radical cystectomy. 
700 1 |a Reicherz, Alina  |e VerfasserIn  |4 aut 
700 1 |a Tully, Karl H.  |e VerfasserIn  |4 aut 
700 1 |a Bahlburg, Henning  |e VerfasserIn  |4 aut 
700 1 |a Maas, Moritz  |e VerfasserIn  |4 aut 
700 1 |a Bach, Peter  |e VerfasserIn  |4 aut 
700 1 |a Klümper, Niklas  |e VerfasserIn  |4 aut 
700 1 |a Eckstein, Markus  |e VerfasserIn  |4 aut 
700 1 |a Hartmann, Arndt  |e VerfasserIn  |4 aut 
700 1 |a Breyer, Johannes  |e VerfasserIn  |4 aut 
700 1 |a Erben, Philipp  |d 1973-  |e VerfasserIn  |0 (DE-588)128501014  |0 (DE-627)373920997  |0 (DE-576)297181661  |4 aut 
700 1 |a Bolenz, Christian  |e VerfasserIn  |4 aut 
700 1 |a Noldus, Joachim  |e VerfasserIn  |4 aut 
700 1 |a Berg, Sebastian  |e VerfasserIn  |4 aut 
700 1 |a Roghmann, Florian  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Urologia internationalis  |d Basel : Karger, 1955  |g 108(2024), 3, Seite 183-189  |h Online-Ressource  |w (DE-627)265510333  |w (DE-600)1464417-4  |w (DE-576)276270991  |x 1423-0399  |7 nnas  |a An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer 
773 1 8 |g volume:108  |g year:2024  |g number:3  |g pages:183-189  |g extent:7  |a An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer 
856 4 0 |u https://doi.org/10.1159/000536321  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://karger.com/uin/article-abstract/108/3/183/894478/An-Empirical-Survey-on-the-Adaption-of-Neoadjuvant?redirectedFrom=fulltext  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250122 
993 |a Article 
994 |a 2024 
998 |g 128501014  |a Erben, Philipp  |m 128501014:Erben, Philipp  |d 60000  |d 63100  |d 60000  |e 60000PE128501014  |e 63100PE128501014  |e 60000PE128501014  |k 0/60000/  |k 1/60000/63100/  |k 0/60000/  |p 11 
999 |a KXP-PPN191534414X  |e 4654954074 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer","title_sort":"empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer"}],"name":{"displayForm":["Moritz J. Reike, Alina Reicherz, Karl H. Tully, Henning Bahlburg, Moritz Maas, Peter Bach, Niklas Klümper, Markus Eckstein, Arndt Hartmann, Johannes Breyer, Philipp Erben, Christian Bolenz, Joachim Noldus, Sebastian Berg, Florian Roghmann"]},"person":[{"given":"Moritz","role":"aut","display":"Reike, Moritz","family":"Reike"},{"display":"Reicherz, Alina","given":"Alina","role":"aut","family":"Reicherz"},{"family":"Tully","display":"Tully, Karl H.","given":"Karl H.","role":"aut"},{"role":"aut","given":"Henning","display":"Bahlburg, Henning","family":"Bahlburg"},{"family":"Maas","display":"Maas, Moritz","given":"Moritz","role":"aut"},{"role":"aut","given":"Peter","display":"Bach, Peter","family":"Bach"},{"family":"Klümper","display":"Klümper, Niklas","given":"Niklas","role":"aut"},{"family":"Eckstein","display":"Eckstein, Markus","role":"aut","given":"Markus"},{"display":"Hartmann, Arndt","given":"Arndt","role":"aut","family":"Hartmann"},{"display":"Breyer, Johannes","given":"Johannes","role":"aut","family":"Breyer"},{"role":"aut","given":"Philipp","display":"Erben, Philipp","family":"Erben"},{"family":"Bolenz","given":"Christian","role":"aut","display":"Bolenz, Christian"},{"display":"Noldus, Joachim","given":"Joachim","role":"aut","family":"Noldus"},{"display":"Berg, Sebastian","given":"Sebastian","role":"aut","family":"Berg"},{"display":"Roghmann, Florian","given":"Florian","role":"aut","family":"Roghmann"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"June 2024","dateIssuedKey":"2024"}],"recId":"191534414X","note":["Online veröffentlich: 19. Januar 2024","Gesehen am 22.01.2025"],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"Basel","dateIssuedKey":"1955","publisher":"Karger","dateIssuedDisp":"1955-"}],"recId":"265510333","note":["Gesehen am 13.04.2021"],"id":{"zdb":["1464417-4"],"issn":["1423-0399"],"eki":["265510333"]},"disp":"An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancerUrologia internationalis","physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"108","text":"108(2024), 3, Seite 183-189","year":"2024","issue":"3","extent":"7","pages":"183-189"},"language":["ger"],"title":[{"subtitle":"an independent international forum for clinically oriented research","title":"Urologia internationalis","title_sort":"Urologia internationalis"}],"pubHistory":["1.1955 -"]}],"physDesc":[{"extent":"7 S."}],"id":{"eki":["191534414X"],"doi":["10.1159/000536321"]}} 
SRT |a REIKEMORITEMPIRICALS2024